Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

Mechanism of intranasal drug delivery directly to the brain

Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences

Advanced Drug Delivery SystemsBarrier Structure and Function Studies

Cited by 721

Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method

Yang, Y. (2001) · Biomaterials

Advanced Drug Delivery SystemsMicroencapsulation and Drying Processes

Cited by 720

Polyhydroxylated alkaloids—Natural occurrence and therapeutic applications

Watson, A. A., Fleet, G. W. J., Asano, N., Molyneux, R. J., & Nash, R. J. (2001) · Phytochemistry

Alkaloids: synthesis and pharmacologyPhytochemistry and Biological Activities

Cited by 714

Society of hair testing guidelines for drug testing in hair

Cooper, G. A. A., Kronstrand, R., & Kintz, P. (2012) · Forensic Science International

Forensic Toxicology and Drug AnalysisAnalytical chemistry methods development

Cited by 712

Off-label prescribing among office-based physicians

Radley, D. C., Finkelstein, S. N., & Stafford, R. S. (2006) · Archives of Internal Medicine

Pharmaceutical industry and healthcarePharmaceutical studies and practices

Cited by 711

Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta

Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science

Pharmacogenetics and Drug MetabolismGut microbiota and health

Cited by 704

Human Sulfotransferases and Their Role in Chemical Metabolism

Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006) · Toxicological Sciences

Pharmacogenetics and Drug MetabolismGlutathione Transferases and Polymorphisms

Cited by 703

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology

Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug Metabolism

Cited by 698

Mammalian Microsomal Cytochrome P450 Monooxygenase

Williams, P. A., Cosme, J., Sridhar, V., Johnson, E. F., & McRee, D. E. (2000) · Molecular Cell

Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation Mechanisms

Cited by 696

Pharmacokinetic aspects of retinal drug delivery

del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research

Advanced Drug Delivery SystemsRetinal Diseases and Treatments

Cited by 693

Approaches for enhancing oral bioavailability of peptides and proteins

Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics

Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems

Cited by 681

Potential problems with the interpretation of hair analysis results

Wennig, R. (2000) · Forensic Science International

Forensic Toxicology and Drug AnalysisForensic and Genetic Research

Cited by 677

Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.

Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., & Proudfoot, A. T. (1979) · BMJ

Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments

Cited by 667

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

Fromenty, B., & Pessayre, D. (1995) · Pharmacology & Therapeutics

Drug-Induced Hepatotoxicity and ProtectionMitochondrial Function and Pathology

Cited by 665

Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences

Honig, P. K. (1993) · JAMA

Pharmacogenetics and Drug MetabolismCardiac electrophysiology and arrhythmias

Cited by 664

Adapting liposomes for oral drug delivery

He, H., Lu, Y., Qi, J., Zhu, Q., Chen, Z., & Wu, W. (2019) · Acta Pharmaceutica Sinica B

Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems

Cited by 663

Increased 2-Hydroxylation of Estradiol as a Possible Mechanism for the Anti-Estrogenic Effect of Cigarette Smoking

Michnovicz, J. J., Hershcopf, R. J., Naganuma, H., Bradlow, H. L., & Fishman, J. (1986) · New England Journal of Medicine

Pharmacogenetics and Drug MetabolismEstrogen and related hormone effects

Cited by 658

Gut microbiome interactions with drug metabolism, efficacy, and toxicity

Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research

Pharmacogenetics and Drug MetabolismGut microbiota and health

Cited by 656

The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism

Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 654

Drug-induced liver injury—types and phenotypes

Hoofnagle, J. H., & Björnsson, E. S. (2019) · New England Journal of Medicine

Drug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug Reactions

Cited by 652

Predicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability

Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews

Drug Solubulity and Delivery SystemsComputational Drug Discovery Methods

Cited by 651

The Missing Voice of Patients in Drug-Safety Reporting

Basch, E. (2010) · New England Journal of Medicine

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical industry and healthcare

Cited by 646

Intranasal Drug Delivery: How, Why and What For?

Pires, A., Fortuna, A., Alves, G., & Falcão, A. (2009) · Journal of Pharmacy & Pharmaceutical Sciences

Advanced Drug Delivery SystemsInhalation and Respiratory Drug Delivery

Cited by 641

Effects of Obesity on Pharmacokinetics: Implications for Drug Therapy

Cheymol, G. (2000) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 631